Company intelligence / Profile preview
QLT Inc.
Vancouver, British Columbia, Canadaorpha.net ↗
- Ownership
- Private
- Employees
- ~102
- Development stage
- Commercial
01
Overview
QLT pioneered light-based therapies for eye disease with Visudyne®, the first approved treatment for age-related macular degeneration. It also developed Eligard®, a long-term injectable prostate cancer therapy using its proprietary Atrigel® technology. The company’s synthetic retinoid program advanced into late clinical stages targeting rare inherited retinal disorders but did not reach commercialization before corporate restructuring and asset divestitures occurred.
- Therapeutic areas
- OphthalmologyOncologyDermatology
- Modalities
- Small moleculesDrug delivery systems (e.g., photodynamic therapy drugs, sustained-release formulations like Atrigel®)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Array BioPharma (cancer research collaboration)Kinetek Pharmaceuticals/Kinetek acquisitionReckitt Benckiser Pharmaceuticals Inc. (Atrigel technology license)
Beyond the preview
Go deeper on QLT Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QLT Inc..